Posted on 06th March 2012
Two patients in the US and one Briton were operated on as part of a global trial by US biotech firm ‘Advanced Cell Technology’ carried out at Moorfields Eye Hospital. Although promising, the researchers said such treatments could still be 10 years away from being available on the NHS.
28th August 2017
What is Myopia Management? Myopia Management is the process of reducing the progression of short-sightedness (Myopia) in children. We do not know exactly what causes children to become more short-s...Read more
10th August 2017
Pre-school vision screening should not negate the need for a comprehensive pre-school eye examination. In Scotland, we are fortunate that all children receive a Pre-School Orthoptic Vision Screenin...Read more